Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

[Heterozygous prothrombin gene mutation G20210A and associated diseases].

La Revue de medecine interne - 1 May 2003

Granel B, Morange P-E, Serratrice J, Ene N, Cremades S, Swiader L, Disdier P, Juhan-Vague I, Weiller P-J

Abstract excerpt

PURPOSE: Prothrombin gene mutation G20210A (factor II) is, in frequency, the second genetic polymorphism involved in venous thrombosis. We report a retrospective studies on 38 patients issued from our medical department, all heterozygous for the factor II mutation and a literature review. METHODS: We have studied 38 patients, all heterozygous for the factor II mutation, selected through a population of 516 tested...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Arteries
Share to France
Share to Genetic Carrier Screening

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Genetic Testing

Share to Prothrombin

Share to Pulmonary Embolism

Share to Thrombosis

Source

Identifiers

PMID: 12763173
DOI: 10.1016/s0248-8663(02)00813-5

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

[Heterozygous prothrombin gene mutation G20210A and associated diseases].PMID 12763173Read ↗

[G20210A transition in the prothrombin gene and venous thromboembolic disease].Semantic proximity Read ↗

Prothrombin G20210A gene mutation, heparin cofactor II defects, primary (essential) thrombocythemia, and thrombohemorrhagic manifestations.Semantic proximity Read ↗

Clinical and Molecular Study of Common Thrombophilia Mutation Prothrombin G20210A.Semantic proximity Read ↗

[20210A mutation of the prothrombin and venous thromboembolism gene].Semantic proximity Read ↗

[Prevalence of Factor V Leiden and the G20210A mutation of the prothrombin gene in a random group of patients with thrombotic episodes].Semantic proximity Read ↗

The prothrombin gene variant 20210A in venous and arterial thromboembolism.Semantic proximity Read ↗

[20210G/A mutation of prothrombin gene in a patient with deep venous thrombosis ad pulmonary embolism without other risk factors of thrombosis].Semantic proximity Read ↗

[Multigenic thrombophilia: genetic anomaly of factor II and mutation of factor V Leiden. Study in a French family].Semantic proximity Read ↗

Inherited thrombophilia: an update.Semantic proximity Read ↗

Increased risk for venous thrombosis in carriers of the prothrombin G-->A20210 gene variant.Semantic proximity Read ↗

[Genetic risk factors of venous thromboembolism].Semantic proximity Read ↗

Prothrombin and the prothrombin 20210 G to A polymorphism: their relationship with hypercoagulability and thrombosis.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.